Navigation Links
Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections

Urinary tract infections (UTI) are often caused by bacteria and are frequently treated with antibiotics, such as fluoroquinolones. Fluoroquinolones have been recommended empirical therapy for treatment of complicated UTIs. Research indicates that Ciprofloxacin has high activity against E. coli that causes the majority of these infections. This new extended release formulation of ciprofloxacin may provide a convenient// once-daily treatment option for these difficult-to treat infections. The once-daily formulation enables the rapid release of ciprofloxacin, which distributes to the serum and tissues within hours. This is followed by a second extended release of the active ingredient, which produces 24-hour urine concentrations.

Research study compared 1000mg once-daily Cipro XR to a twice-daily 500 mg dose of conventional Cipro. Patients were evaluated based on the presence of UTI. Evaluation was based on bacteriologic and clinical outcomes. Bacteriological eradication was achieved in 89 percent of patients treated with once-daily Cipro XR and 85 percent of patients treated with conventional twice-daily Cipro. Clinical cure was observed in 97 percent of patients treated once a day with Cipro XR 1000mg, compared with 94 percent of patients receiving the traditional Cipro 500mg twice daily. This indicates safety and efficacy profile of once-daily Cipro(R) XR is Comparable to Conventional CIPRO(R) in treating Complicated Urinary Tract Infections.

Page: 1

Related medicine news :

1. Treating eye pain eases migraine
2. Treating wounds without stitches
3. Treating varicose veins
4. Treating acne with laser
5. Treating Stroke Patients in Rural Areas
6. Free Tissue Transfer Effective in Treating Massive Skin Cancers
7. Treating Blocked Arteries In The Lower Limbs
8. Zinc Supplements Found To Be Effective In Treating Children With ADHD
9. Hormone Leptin Found To Be Effective In Treating Women With Infertility Problems
10. Treating Depression In Children Could Lead To Poor Bone Development
11. The Effect Of Pain Relievers In Treating Kids With Migraine Questioned
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: